43rd week of 2010 patent applcation highlights part 47 |
Patent application number | Title | Published |
20100273842 | AMINE DERIVATIVES HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY AND THE USES THEREOF - This invention provides an anorectic or anti-obesity composition comprising a compound of the formula (I): | 2010-10-28 |
20100273843 | HETEROCYCLIC SELF-IMMOLATIVE LINKERS AND CONJUGATES - The present invention provides heterocyclic linker compounds useful for linking drug moieties to ligands. The compounds also include drug-ligand conjugates comprising a ligand capable of targeting a selected cell population, and a drug connected to the ligand by a heterocyclic linker moiety. The linker moiety comprises a peptide sequence that is a substrate for an intracellular enzyme, for example a cathepsin, that cleaves the peptide at an amide bond. The peptide further contains a self-immolating moiety which connects the drug and the protein peptide sequence. Upon cleavage of the peptide sequence by an intracellular enzyme the self-immolating moiety cleaves itself from the drug moiety such that the drug moiety is in an underivatized and active form. | 2010-10-28 |
20100273844 | PHARMACEUTICAL COMPOSITIONS FOR TREATING OR PREVENTING MIGAINES - The present invention provides a method for treating or preventing one or more types of migraines by administering a monoamine oxidase inhibitor, preferably isocarboxazid, in a rapid-release formulation. The present invention also provides a pharmaceutical composition suitable for treating or preventing migraines and having at least one monoamine oxidase inhibitor. | 2010-10-28 |
20100273845 | ANGIOTENSIN II RECEPTOR ANTAGONISTS - A compound having the structure | 2010-10-28 |
20100273846 | METHOD FOR TREATING PROLIFERATIVE DISORDERS ASSOCIATED WITH MUTATIONS IN C-MET - The present invention relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for treating c-Met associated cancers, in a subject in need thereof. | 2010-10-28 |
20100273847 | DESFERRIOXAMINE CONJUGATES, DERIVATIVES AND ANALOGUES - The present invention relates to desferoxamine conjugates, derivatives and analogues thereof. In particular, the present invention relates to desferoxamine conjugates, analogues and derivatives thereof, and methods for reducing levels of metals, especially iron, in a mammal. Uses of the compounds according to the invention are also provided. Compounds of the present invention may also be used to treat iron dyshomeostasis disorders, cancer, malaria and fungal infections. The compounds of the invention may be formulated into a pharmaceutical composition or packaged into kits. | 2010-10-28 |
20100273848 | IMINOPYRROLIDONE THIOL AMINO ACID CONJUGATES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER - Compounds, compositions and methods for the treatment of cancer are disclosed herein. Embodiments of the present invention include compounds having the formula: (I), wherein R1 is selected from hydrogen or substituted or unsubstituted (C | 2010-10-28 |
20100273849 | Metalloproteinase Inhibitors - Compounds of the formula (I) wherein Z is SO | 2010-10-28 |
20100273850 | 4-HETEROARYL-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES - Compounds of Formula I: I in which D | 2010-10-28 |
20100273851 | METHODS OF USING PROTEINACIOUS CHANNELS TO IDENTIFY PHARMACEUTICAL TREATMENTS AND RISKS, AND TREATMENTS RESULTING THEREFROM - Methods and therapeutic strategies utilizing proteinacious channels in lipid membranes of mammalian cells. The methods entail administering a pharmaceutical to a lipid membrane of a mammalian cell, and then determining the effect of the pharmaceutical on the electrophysiology of at least one proteinacious channel of the lipid membrane, wherein the proteinacious channel is a Kv7 potassium channel and/or a L-type calcium channel of an airway smooth muscle cell (ASMC). The method can be used to identify pharmaceuticals that may be used to treat asthmatic and other bronchospastic conditions that can lead to airway obstruction, or to perform drug screening to assess potential risk of pharmaceuticals. | 2010-10-28 |
20100273852 | PHARMACEUTICAL COMPOSITION - There is provided a pharmaceutical composition comprising (1) (R)-5,6-dimethoxy-2-[2,2,4,6,7-pentamethyl-3-(4-methylphenyl)-2,3-dihydro-1-benzofuran-5-yl]isoindoline, (2) a lipophilic component, and (3) a surfactant, which can stably and sufficiently provide improvement in the absorbability of the drug without being affected by the amount and quality of a meal. | 2010-10-28 |
20100273853 | NOVEL ISOINDOL DERIVATIVES AS EP4 RECEPTOR AGONISTS - A compound of formula (1) or a pharmaceutically acceptable derivative thereof, | 2010-10-28 |
20100273854 | COMPOSITIONS AND METHODS FOR INHIBITING NADPH OXIDASE EXPRESSION - One or more inhibitors, in particular siRNAs, which down-regulate the expression of a NOX gene selected from the group consisting of NOX4, NOXI, NOX2 (gp91phox, CYBB), NOX5, DUOX2, NOXOI, NOXAI and NOXA2 (p67phox) is disclosed. Also provided is a vector capable of expressing the compound A method is provided for treating or preventing the incidence or seventy of various diseases or conditions associated with NOX gene compπsing administering to the patient the inhibitor in a pharmaceutical composition | 2010-10-28 |
20100273855 | COMPOSITIONS AND METHODS OF TREATING CANCER - The invention features a method for treating cancer by administering a double-stranded nucleic acid molecule against a CX gene selected from the group consisting of C14orf78, MYBL2, UBE2S and UBE2T. The invention also features products, including the double-stranded nucleic acid molecules and vectors encoding them, as well as compositions comprising the molecules or vectors, useful in the provided methods. The methods of the invention are suited for the treatment of cancers including lung cancer, breast cancer, bladder cancer, esophagus cancer, prostate cancer, cholangiocellular carcinoma and testicular seminoma. | 2010-10-28 |
20100273856 | SCREENING OF MICRO-RNA CLUSTER INHIBITOR POOLS - The disclosure provides methods for inhibiting the activity of a miRNA cluster in a cell, and also for screening a cell for a phenotype(s) of interest resulting from inhibition of a miRNA cluster. The methods use a cluster pool which comprises at least one miRNA inhibitor specific for each miRNA in the miRNA cluster. MiRNA inhibitors are described that induce apoptosis in breast cancer cells and hence are useful in the treatment of breast cancer. The disclosure also provides pharmaceutical compositions which are useful for the treatment of breast cancer; methods for inducing the nuclear translocation of NF-κB in a breast cancer cell; methods for inducing the nuclear translocation of c-Jun in a breast cancer cell; method for inhibiting the nuclear translocation of NF-κB in a breast cancer cell; and methods for providing prognostic medical information relating to breast cancer progression. | 2010-10-28 |
20100273857 | SUPPRESSION OF SCN9A GENE EXPRESSION AND/OR FUNCTION FOR THE TREATMENT OF PAIN - Disclosed herein are methods, sequences and nucleic acid molecules used to treat pain. Specifically, the methods and sequences include locally administering molecules that suppress the expression of amino acid sequences that encode for Na | 2010-10-28 |
20100273858 | COMPOSITIONS COMPRISING STAT5 SIRNA AND METHODS OF USE THEREOF - The present invention provides nucleic acid molecules that inhibit STAT5 expression. Methods of using the nucleic acid molecules are also provided. | 2010-10-28 |
20100273859 | TREATMENT AND PREVENTION OF HIV INFECTION - Disclosed herein are methods for treating and/or preventing HIV infection in a cell. The methods involve downmodulating one or more of the HIV-dependency factors (HDFs) disclosed herein to thereby treat and/or prevent HIV infection in the cell. Downmodulating the HDFs can be by contacting the cell with an agent that downmodulates the HDF. Also disclosed herein are methods for treating and/or preventing HIV infection in a subject comprising downmodulating one or more of the HIV-dependency factors (HDFs), disclosed herein, to thereby treat and/or prevent HIV infection in the subject. The method may further comprise selecting a subject diagnosed with or at risk for HIV infection, prior to downmodulating. Downmodulating the HDFs may comprise administering an agent that downmodulates the HDF to the subject such that the agent contacts HIV host cells of the subject. The agent may inhibit HDF gene expression, protein synthesis, HDF function or HDF activity, or combinations thereof. | 2010-10-28 |
20100273860 | MODULATION OF APOLIPOPROTEIN (a) EXPRESSION - Compounds, compositions and methods are provided for modulating the expression of apolipoprotein(a). The compositions comprise oligonucleotides, targeted to nucleic acid encoding apolipoprotein(a). Methods of using these compounds for modulation of apolipoprotein(a) expression and for diagnosis and treatment of disease associated with expression of apolipoprotein(a) are provided. | 2010-10-28 |
20100273861 | MYCOBACTERIAL PEPTIDE DEFORMYLASE - The present invention relates to the design of the Antisense-oligonucleotide complementary to the specific region of peptide deformylase gene from | 2010-10-28 |
20100273862 | Phosphatases which activate map kinase pathways - The present invention provides novel JNK activating phosphatase polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing JNK activating phosphatase polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with JNK activating phosphatase polypeptides. | 2010-10-28 |
20100273863 | Modulation of Gene Expression Using Oligomers That Target Gene Regions Downstream of 3' Untranslated Regions - Gene expression can be selectively modulated by contacting a cell with an oligomer that targets a gene region downstream of a ′3-UTR, thereby increasing or decreasing the expression of the target gene. | 2010-10-28 |
20100273864 | CONTROLLED RELEASE AURIS SENSORY CELL MODULATOR COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS - Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with auris sensory cell modulating agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s). | 2010-10-28 |
20100273865 | Polypeptides involved in neuronal regeneration-associated gene expression - The present invention relates to methods for promoting regeneration response of peripheral and central nervous systems in mammals in need of such biological effects. The methods comprise altering the activity or steady state level of specific transcription factors that control regeneration of injured or degenerated neuronal cells. Preferably the activity or steady state level of specific transcription factors is altered by introducing nucleic acids to increase or decrease expressing of these transcription factors. These are useful in or suffering from neurodegenerative disorders. | 2010-10-28 |
20100273866 | DIAGNOSIS AND TREATMENT OF CANCER: I - A method of diagnosing cancer comprising the steps of (i) obtaining a sample containing nucleic acid and/or protein from the patient; and (ii) determining whether the sample contains a level of SCN5A (and optionally also SCN9A) voltage-gated Na+ channel nucleic acid or protein associated with cancer. A method of diagnosing breast cancer comprising the steps of (i) obtaining a sample containing nucleic acid and/or protein from the patient; and (ii) determining whether the sample contains a level of voltage-gated Na+ channel nucleic acid or protein, preferably SCN5A or SCN9A, associated with cancer. A method of treating cancer comprising the step of administering to the patient an agent which selectively prevents the function of SCN5A (and optionally also SCN9A) voltage-gated Na+ channel. A method of treating breast cancer comprising the step of administering to the patient an agent which selectively prevents the function of a voltage-gated Na+ channel, preferably SCN5A or SCN9A. Genetic constructs and molecules useful in such methods. The methods and compositions are particularly suited to breast cancer. | 2010-10-28 |
20100273867 | THERAPY-ENHANCING GLUCAN - A therapeutic composition for treatment of cancer in a mammal is disclosed. The composition comprises an effective amount of a glucan composition which is suitable for oral administration and for absorption through the gastrointestinal tract of the mammal, and at least one antibody for the cancer. A method of treating cancer in a mammal is also disclosed. The method comprises administering a suitable orally administered glucan and at least one antibody for the treatment of cancer to the mammal. In addition a composition for delivery of peptide, protein, RNA, DNA or plasmid comprising effective amount of a beta-glucan is disclosed. | 2010-10-28 |
20100273868 | R-Zileuton for Use in Conditions Associated with Increased 5-Lipoxygenase and/or Leukotriene Activity (EG Asthma) - The invention pertains to a method of treating a condition mediated by or characterized by increased 5-lipoxygenase activity like for instance asthma in a patient suffering therefrom comprising administering to said patient a composition comprising (R)-zileuton and a pharmaceutically acceptable excipient, wherein said composition is substantially free of (S)-zileuton. | 2010-10-28 |
20100273869 | ANTI-CANCER TOCOTRIENOL ANALOGUES AND ASSOCIATED METHODS - Compounds are disclosed relating to the treatment of cancer that include tocotrienols and derivatives of tocotrienols including 2,5,7,8-tetramethyl-2-((3E,7E)-4,8,12-trimethyltrideca-3,7,11-trienyl)chroman-6-ylphenylsulfonylcarbamate; (R)-2,8-dimethyl-2-((3E,7E)-4,8,12-trimethyltrideca-3,7,11-trienyl)chroman-6-yl tosylcarbamate; and (R)-2,5,7,8-tetramethyl-2-((3E,7E)-4,8,12-trimethyltrideca-3,7,11-trienyl)chroman-6-yl benzylcarbamate. Therapeutic uses of these types of compounds are also taught. | 2010-10-28 |
20100273870 | COMPOSITIONS AND METHODS FOR TREATING DEMODEX INFESTATIONS - Compositions containing about 0.6% to about 20% of tea tree oil are described. Some compositions are in the form of solutions, suspensions, spray, lotions, gels, pastes, medicated sticks, balms, cleansers (including shampoos and soaps), creams, or ointments. Also described are compositions and methods for use in treating ocular | 2010-10-28 |
20100273871 | ANTICANCER TOCOPHERYL SUCCINATE DERIVATIVES - Compounds of formula I: | 2010-10-28 |
20100273872 | USE OF 4-OXOBUTANOIC ACID DERIVATIVES IN THE TREATMENT OF PATHOLOGIES ASSOCIATED WITH IMMUNOLOGICAL DISORDERS - The present invention relates to the use of a 4-oxobutanoic acid derivative for the preparation of a pharmaceutical composition for the treatment of pathologies associated with immunological disorders. | 2010-10-28 |
20100273873 | DIRECT COMPRESSIBLE DEXTROSE - This invention relates to a direct compressible dextrose composition, a process for preparing such a direct compressible dextrose composition by compression and subsequent granulation, and processes for preparing pharmaceutical formulations or food formulations in tablet form using the direct compressible dextrose composition. The invention further concerns pharmaceutical or food formulations, which comprise the directly compressible dextrose composition, and the use of the direct compressible dextrose composition for the preparation of pharmaceutical and food formulations. | 2010-10-28 |
20100273874 | USE OF PROPINEB AS BIRD REPELLENT - The present invention relates to the novel use of Propineb as bird repellent. | 2010-10-28 |
20100273875 | Composition for External Application to Skin - A composition for external application to skin, containing a compound represented by formula (I) or a salt thereof, and/or a quaternary ammonium salt represented by formula (II): | 2010-10-28 |
20100273876 | ANTIBACTERIAL FORMULATION COMPRISING A DIALKYL SULPHOSUCCINATE AND A CARBANILIDE ANTIBACTERIAL AGENT - Antibacterial formulation containing (a) a dialkyl sulphosuccinate (DAS) or derivative thereof and (b) a carbanilide antibacterial agent such as triclocarban (TCC). The formulation may be for use in the treatment of a bacterial condition, in particular acne, body odour or a condition affecting the oral cavity. It may contain, in addition to the DAS and the carbanilide, (i) a poly-oxyalkylene-based solubilising agent; (ii) an organic solvent; (iii) a thickening agent; and (iv) water. | 2010-10-28 |
20100273877 | EMULSIFIED SKIN EXTERNAL PREPARATIONS AND COSMETICS - An emulsified skin external preparation including 0.01 to 10% by mass of a branched acyl carnitine derivative represented by the following Formula (1) and/or a carnitine derivative salt represented by the following Formula (2), and 0.01 to 20% by mass of a nonionic surfactant: | 2010-10-28 |
20100273878 | PREVENTIVE OR THERAPEUTIC DRUG FOR ALZHEIMER-TYPE DEMENTIA - It is intended to provide a highly safe preventive or therapeutic drug for Alzheimer-type dementia which can replace the conventional therapies currently used for Alzheimer-type dementia or which can be used together with the conventional therapy to realize high therapeutic effects, characterized in that a ω-3 polyunsaturated fatty acid and thyroid hormone are used in combination. | 2010-10-28 |
20100273879 | Method For Producing Acylglycinates - The invention relates to a method for producing acylglycinates of formula (I) | 2010-10-28 |
20100273880 | STORAGE-STABLE AQUEOUS COMPOSITION COMPRISING A MAGNESIUM COMPOUND AND L-CARNITINE - The present invention relates to a storage-stable aqueous or gel-like composition or solution comprising a magnesium compound selected from a magnesium salt or a magnesium complex compound, and L-carnitine, and the use thereof for the preparation of a medicament for supporting metabolism, in particular in muscle tissue, and for supporting muscle structure, and its use as food supplement or in the veterinary sector as animal feed additive, in particular for horses, poultry, pigeons, pigs, cattle, sheep and camels. | 2010-10-28 |
20100273881 | LIPID COMPOSITIONS FOR THE TREATMENT OF GASTRO-INTESTINAL DISORDERS AND THE PROMOTION OF INTESTINAL DEVELOPMENT AND MATURATION - The present invention provides a use of a lipid composition for the preparation of a nutritional, pharmaceutical or nutraceutical composition or a functional food, for the prevention and treatment of gastrointestinal diseases and disorders, and for promoting intestinal development, maturation, adaptation and differentiation. | 2010-10-28 |
20100273882 | METHOD FOR THE TREATMENT OF ACNE USING COMPOSITIONS COMPRISING 0.3% BY WEIGHT OF 6-[3-(1-ADAMANTYL)-4-METHOXYPHENYL]-2-NAPHTHOIC ACID - Dermatological disorders having an inflammatory or proliferative component, notably common acne, are treated with topically applicable pharmaceutical compositions containing about 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) or salt thereof, formulated into pharmaceutically acceptable media therefor, advantageously formulated into topically applicable gels, preferably aqueous gels, creams, lotions or solutions. | 2010-10-28 |
20100273883 | Novel ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof - Novel ligand compounds having the structural formula (I): | 2010-10-28 |
20100273884 | METHOD FOR STABLE AND CONTROLLED DELIVERY OF (-)-HYDROXYCITRIC ACID - The present invention provides stable encapsulated (−)-hydroxycitric acid (“HCA”)-containing compositions and methods of making the same. A method is provided by which the hygroscopic salts of HCA in their relatively pure and active forms, including especially the potassium salt, but also including the sodium salt, are rendered non-hygroscopic and stable (that is, not prone to lactonization, not readily subject to attachment to ligands which inhibit absorption or lead to excretion, and so forth) such that these HCA salts might be included in dry delivery formats, liquid delivery and in controlled-release vehicles. The nonhygroscopic salts of HCA and its derivatives likewise may be protected against acid degradation, lactonization and undesirable ligand binding when exposed to acidic environments or other challenging conditions. The method taught herein can be employed to reduce the polar/ionic qualities of HCA salts and derivatives when presented to the intestinal lumen to provide advantages in absorption. | 2010-10-28 |
20100273885 | LOW ENVIRONMENTAL IMPACT PESTICIDE MADE FROM "GRAS" INGREDIENTS FOR USE AGAINST COQUI FROGS AND OTHER SPECIES - The current invention involves compositions and methods for killing various soft-bodied animals of interest (more specifically, Coqui frogs and Coqui frog eggs are targeted) with a low pH adjusted pesticide. The method involves contacting the soft-bodied animal of interest with the low pH adjusted pesticide, wherein the pesticide is a propionic acid composition, a citric acid composition, an Acidic Calcium Sulfate (ACS) composition, or combination thereof. The preferred pesticide composition has a working concentration that is less than about 15% (w/v), and a pH less than about pH 2.5, which has a lethal effect on Coqui frogs, but is less phytotoxic than higher concentration pesticides. The method includes spraying any of the pH adjusted pesticides thoroughly an area inhabited by the soft-bodied animals of interest, which includes the under brush, under bushes, and typically any hiding places. On a large scale, the method contemplates filling various types of industrial spraying equipment with the pesticide and saturating entire pest inhabited areas. | 2010-10-28 |
20100273886 | FORMULATIONS AND METHODS FOR LYOPHILIZATION AND LYOPHILATES PROVIDED THEREBY - The present invention provides compositions, methods for lyophilizing compounds and making pharmaceutical compositions, and kits providing solutions and lyophilized formulations of compounds. The compositions, methods, and kits are particularly useful in pharmaceutical applications involving therapeutic agents that have low solubility at low pH and medium pH values. Certain embodiments provide methods for lyophilizing compounds in liquid solutions, which include the steps of: a) preparing aqueous solutions of a compound of interest in the absence of buffer; b) adjusting the pH to high values of pH in order to increase the solubility of the compound of interest; and c) freeze-drying the solution to provide a lyophilized solid composition. Aqueous solutions including buffer are also disclosed. Lyophilized formulations, including micronized and non-micronized powders, are provided. | 2010-10-28 |
20100273887 | MIXTURES COMPRISING PELLITORIN AND USES THEREOF - The present invention relates to products and mixtures comprising (a) pellitorin and (b) selected cooling agents. The present invention further relates to products and medicaments for soothing irritated oral and/or nasal tissues. The present invention also relates to the use of such mixtures for soothing irritated oral and/or nasal tissues and the use of such mixtures for reducing bitterness, in particular the bitterness of oral care products, confectionery products and medicaments, more specifically reducing the bitterness of menthol and menthol containing products and medicaments. | 2010-10-28 |
20100273888 | POLYQUATERNIUM-1 SYNTHESIS METHODS AND ASSOCIATED FORMULATIONS - A multipurpose solution for contact lens care, comprising: an aqueous liquid medium; a quaternary ammonium polymer having an average molecular weight as determined by the proton NMR method of at least 28 k, and methods for making the same. | 2010-10-28 |
20100273889 | USE OF A BETA BLOCKER FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF HEMANGIOMAS - The present invention relates the use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas, for example of infantile hemangiomas. The beta blocker may be a non-selective beta-blocker, for example propranolol. The present invention provides an alternative to the known compounds, e.g. corticosteroids, interferon or vincristine, generally used for the treatment of hemangiomas. | 2010-10-28 |
20100273890 | IDENTIFICATION OF BACTERIAL AUTOINDUCER AND USE IN TREATING BACTERIAL PATHOGENICITY - A bacterial autoinducer, CAI-1, was purified and its structure identified. Methods for synthesis of the autoinducer and its analogues were elucidated. Methods of using the autoinducer or its analogues for treating bacterial pathogenicity and bio film formation are described. Methods for prevention and treatment of cholera are described. Synthetic (S)-3-hydroxytridecan-4-one functions as well as natural CAI-1 in repressing production of the virulence factor toxin co-regulated pilus (TCP). Strategies are described to manipulate bacterial quorum sensing in the clinical arena. | 2010-10-28 |
20100273891 | ISOFLAVONE METABOLITES - There are disclosed compounds of formulae (I) or (II) in which A is selected from the group consisting of (1), (2), (3) and (4); OH, and one of R | 2010-10-28 |
20100273892 | FORMULATIONS OF TOCOTRIENOL QUINONES FOR THE TREATMENT OF OPHTHALMIC DISEASES - A formulation, comprising an ophthalmically effective amount of one or more tocotrienol quinones, particularly of alpha-tocotrienol quinone is disclosed. Use of a formulation comprising one or more tocotrienol quinones for the prevention, reduction, amelioration or treatment of ophthalmic disorders that are associated with a neurodegenerative or trauma disorder is also discussed. A method of treating or controlling the ocular symptoms associated with neurodegenerative diseases or trauma with a formulation comprising one or more tocotrienol quinones is also discussed. A method of treating or controlling the ocular symptoms associated with mitochondrial myopathies with a formulation comprising one or more tocotrienol quinones is also discussed. | 2010-10-28 |
20100273893 | PROTECTIVE EFFECT OF THYMOQUINONE IN SPESIS - The present invention refers to thymoquinone, a main constituent of the volatile oil of | 2010-10-28 |
20100273894 | TREATMENT OF LEBER'S HEREDITARY OPTIC NEUROPATHY AND DOMINANT OPTIC ATROPHY WITH TOCOTRIENOL QUINONES - The present invention relates to methods of treating Leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones, including alpha-tocotrienol quinone, in order to alleviate symptoms of the disease. | 2010-10-28 |
20100273895 | FORMULATIONS OF CANNABIDIOL AND PRODRUGS OF CANNABIDIOL AND METHODS OF USING THE SAME - Described herein are pharmaceutical compositions comprising a cannabinoid, such as cannabidiol or a cannabidiol prodrug, which is metabolized to cannabidiol, and a penetration enhancer. Also described herein are methods of using the same. One embodiment described herein relates to the transdermal or topical administration of pharmaceutical compositions comprising a cannabinoid, such as cannabidiol or a cannabidiol prodrug, and a penetration enhancer to a person in need thereof. | 2010-10-28 |
20100273896 | Method for producing products with water clusters - A method of producing products includes diluting a mater in a quality water as a dilution water a plurality of times until solid stable water clusters are formed having a plurality of water molecules connected with one another by electrical dipole interaction via internal electric field of ions and having a permanent electric dipole moment with an electrical field surrounding the solid stable water clusters, and the produced solid stable water clusters can be used with an additional material to produce the final product. | 2010-10-28 |
20100273897 | AQUEOUS FUNGICIDAL COMPOSITION AND USE THEREOF FOR COMBATING HARMFUL MICROORGANISMS - The invention relates to aqueous fungicidal active substance compositions and to their use in the control of harmful microorganisms and in particular in the protection of cellulose-comprising materials, particularly wood, from infection by microorganisms, in particular those harmful fungi which can damage wood or cellulose. | 2010-10-28 |
20100273898 | METHOD FOR PRODUCING EMULSION AND THEREBY OBTAINED EMULSION - An object of the invention is to provide a uniform emulsion that can be produced with a low energy and does not require classification operation; and provided is a method for producing an emulsion, wherein at least a fluid to be processed that forms continuous phase and a fluid to be processed that forms dispersed phase are mixed in a thin film fluid formed between processing surfaces arranged to be opposite to each other so as to be able to approach to and separate from each other, at least one of which rotates relative to the other, whereby the emulsion having variation coefficient of 0.3 to 30% in a particle size distribution is obtained. | 2010-10-28 |
20100273899 | INTEGRATED, HIGH-EFFICIENCY PROCESSES FOR BIOMASS CONVERSION TO SYNTHESIS GAS - The present invention provides several variations for converting biomass, and other carbon-containing feedstocks, into syngas. Some variations include pyrolyzing or torrefying biomass in a devolatilization unit to form a gas stream and char, and gasifying the char. Other variations include introducing biomass into a fluid-bed gasifier to generate a solid stream and a gas stream, followed by a partial-oxidation or reforming reactor to generate additional syngas from either, or both, of the solid or gas stream from the fluid-bed gasifier. Hot syngas is preferably subjected to heat recovery. The syngas produced by the disclosed methods may be used in any desired manner, such as conversion to liquid fuels (e.g., ethanol). | 2010-10-28 |
20100273900 | Process for Producing Liquid and Gaseous Products from Gaseous Reactants - A hydrocarbon synthesis process ( | 2010-10-28 |
20100273901 | MOLECULE SULFONATION PROCESS - The present invention pertains to products and processes relating to sulfonating molecules, including nucleic acids, amino acids, peptides, polypeptides, oligomers, polymers, and copolymers. The disclosed process allows for a uniform and controlled level of sulfonating molecules. The sulfonated molecules produced by the disclosed process exhibit a high degree of uniform sulfonation as well as improved properties. | 2010-10-28 |
20100273902 | DURABLE CONCRETE COMPOSITIONS - Methods of controlling the durability of and/or the amount of air in concrete formulations that include combining cement, water, and optionally aggregates, admixtures and/or additives to form a cement mixture; and adding prepuff particles to the cement mixture to form a concrete formulation. The prepuff particles have an average particle diameter of from 0.2 mm to 3 mm, a bulk density of from 0.015 g/cc to 0.35 g/cc, an aspect ratio of from 1 to 3, and a smooth continuous outer surface. The cured and hardened concrete formulation typically has a relative dynamic modulus of at least 70% determined according to Procedure A of ASTM C666 (2003). The amount of air in the concrete typically increases over the amount of air in similar formulations not containing prepuff particles, as determined according to ASTM C231, based on the volume percent of prepuff. The concrete formulations can be used to make articles. | 2010-10-28 |
20100273903 | HEAT-FOAMABLE SHEET, PRODUCING METHOD THEREFOR, AND FOAM FILLING MEMBER - The present invention provides a heat-foamable sheet that foams uniformly and omnidirectionally, a method for producing the heat-foamable sheet, and a foam filling member including the heat-foamable sheet. A heat-foamable sheet having a horizontal to vertical ratio of 1.5 or less when heated at 160° C. for 20 minutes is obtained by a method for producing a heat-foamable sheet including: an extrusion step of extruding a heat-foamable material containing a polymer and a foaming agent into an isotropy-containing shape including an isotropic portion of a generally arc shape; and a sheet-forming step of forming the heat-foamable material that is extruded in the extrusion step into a sheet shape. | 2010-10-28 |
20100273904 | PROCESS FOR PRODUCING POLYPROPYLENE RESIN FOAM - Disclosed is a process for producing a polypropylene-based resin foam by subjecting a linear polypropylene-based resin, which has a melt tension at 230° C. of from 5 to 30 g and satisfies the below-described formula (1) in which MFR stands for a melt flow rate of the linear polypropylene-based resin at 230° C. and MT stands for the melt tension at 230° C., to melt extrusion through an extruder while injecting carbon dioxide into the resulting molten resin to foam the molten resin. The process includes subjecting the extruder to temperature control such that the extruder has a temperature of from 200 to 240° C. at a position of a cylinder barrel thereof, where the carbon dioxide is to be introduced, and the cylinder barrel has a temperature of from 175 to 190° C. at a position before the foaming; and then discharging the molten resin into atmospheric pressure with a discharge rate of the molten resin per opening area of a die being controlled to give a resin pressure of from 5 to 20 MPa at a position immediately proximal to an opening of the die, thereby foaming the molten resin. The process of the present invention can provide a polypropylene-based resin foam having a high expansion ratio, uniformly dispersed foam cells and a good surface appearance. | 2010-10-28 |
20100273905 | THERMOPLAST-CONTAINING EPOXY RESINS AND THE PROCESSING THEREOF BY EXTRUSION OR INJECTION MOLDING - The invention relates to a material mixture comprising at least one epoxy resin and a thermoplast, selected from such copolymers that comprise at least three different monomers. Preferably, the thermoplast is selected from such where at least one monomer is a hydrocarbon without heteroatoms and with at least one C═C double bond and where at least one other monomer is an optionally substituted acrylate or an optionally substituted acrylic acid ester. The invention also relates to a material mixture of said kind that additionally comprises the following components: at least one blowing agent, at least one hardener and at least one filler. The invention relates to methods for the production of molded bodies made from said material mixture, to the molded bodies and the use thereof for structural reinforcement. | 2010-10-28 |
20100273906 | ATOM TRANFER DISPERSION POLYMERIZATION - The present disclosure describes a two-step batch dispersion polymerization process for the preparation of substantially uniformed-sized functional (co)polymer particles. The first step of the process includes polymerizing at least one first radically (co)polymerizable monomer by a free radical polymerization process to form a (co)polymer in a stable colloidal dispersion and the second step includes polymerizing the at first radically (co)polymerizable monomer or an additional radically (co)polymerizable monomer in the stable colloidal dispersion by a living/controlled radical (co)polymerization process. | 2010-10-28 |
20100273907 | MODIFIED OPEN-CELL FOAMS AND PROCESS FOR THEIR PRODUCTION - Modified open-cell aminoplastic foams with a density in the range from 5 to 1,000 kg/m | 2010-10-28 |
20100273908 | NCO PREPOLYMERS HAVING A LOW CONTENT OF FREE MONOMERIC DIISOCYANATE, AND THE PRODUCTION THEREOF - The present invention relates to NCO prepolymers having a low content of free monomeric diisocyanate, to a process for the production of these NCO prepolymers, to polyurethanes prepared from these NCO prepolymers and to processes for the production of these polyurethanes. | 2010-10-28 |
20100273909 | URETHANE (METH)ACRYLATE OBLGOMER AND SHEET USING THE SAME - Disclosed is a urethane (meth)acrylate oligomer which is obtained by reacting at least one polyoxyalkylene polyol (A), at least one monool (B1) soluble in the component (A) and/or at least one silane coupling agent (B2) reactive with an isocyanate group, at least one polyisocyanate (C) and at least one hydroxylated mono(meth)acrylate compound (D) at a ratio at which the equivalent weights of hydroxy groups, active hydrogen groups and isocyanate groups in the respective components satisfy the following formulae (1)-(3). The urethane (meth)acrylate oligomer does not substantially contain an unreacted isocyanate group. B(active hydrogen)+D(OH)=C(NCO)−A(OH) (1) 1.05≦C(NCO)/A(OH)≦2 (2) {C(NCO)−2A(OH)+2 m}×0.35≦D(OH)≦{C(NCO)−2A(OH)+2 m}×0.70 (3) In the formulae (1)-(3), A(OH) represents the total equivalent weight of hydroxy groups contained in the component (A); B(active hydrogen) represents the total equivalent weight of active hydrogen groups contained in the component (B1) and/or the component (B2); C(NCO) represents the total equivalent weight of isocyanate groups contained in the component (C); D(OH) represents the total equivalent weight of hydroxy groups contained in the component (D); and m represents the number of moles of the component (A). | 2010-10-28 |
20100273910 | POLYNITRONES AND USE THEREOF FOR CROSS-LINKING UNSATURATED POLYMERS - The present invention relates to polyfunctional nitrones (optionally in the form of nitrone-terminated polymers) and to their use as crosslinking agents and matting agents, preferably for producing stable molding compounds, knifing fillers, and use thereof in inks, coatings, and adhesives. Low crosslinking temperatures characterize the invention. Through the use of polyfunctional nitrones it is possible for all unsaturated polymers to be cured, solidified and/or structured at low temperatures, preferably without use of a catalyst. Depending on the amount of nitrone-terminated polymers and/or low molecular mass polyfunctional nitrone used it is possible to exert a strong influence over the optical and the mechanical properties of the coated surfaces. By optical properties are meant, among others, the gloss of the coating systems and the surface structuring, e.g., the matt effect. | 2010-10-28 |
20100273911 | MULTI-SOLUTION BONE CEMENTS AND METHODS OF MAKING THE SAME - The present invention relates to bone cements and, more particularly, to acrylic-based orthopedic bone cements, their use in spinal applications, and methods for making the same. An embodiment of the present invention provides a method of grafting PMMA brushes on cross-linked PMMA nanospheres comprising at least one of the following steps: performing a hydrolysis reaction of surface methyl ester groups of said cross-linked PMMA nanospheres to form surface carboxylic acid groups of said cross-linked PMMA nanospheres; forming a 2-aminoethyl acrylate compound; coupling said surface carboxylic acid groups of said cross-linked PMMA nanospheres with said 2-aminoethyl acrylate compound to form a coupled compound with an initiating site; and grafting said PMMA brushes onto said initiating site. Another embodiment of the present invention includes an orthopedic bone cement including cross-linked PMMA nanospheres comprising PMMA brushes prepared by this method, and a monomer, wherein polymer to monomer ratio is between about 1:1 and 1.3:1. | 2010-10-28 |
20100273912 | Cement Compositions Comprising Latex and a Nano-Particle - Methods and compositions are provided that may comprise cement, a nano-particle, latex, and water. An embodiment of the present invention includes a method of cementing in a subterranean formation. The method may include introducing a cement composition into the subterranean formation, wherein the cement composition comprises cement, a nano-particle, latex, and water. The method further may include allowing the cement composition to set in the subterranean formation. Another embodiment of the present invention include a cement composition. The cement composition may comprise cement, a nano-particle, latex, and water. | 2010-10-28 |
20100273913 | CLAY MINERAL PRODUCTS AND THEIR USE IN RUBBER COMPOSITIONS - Disclosed herein is a rubber composition comprising a rubber and particulate kaolin clay as a filler wherein: the kaolin particles have a particle size distribution such that at least about | 2010-10-28 |
20100273914 | CRAYON - The invention provides a crayon which comprises an alternative plasticizer in place of the conventional phthalate ester plasticizers and yet provides writings excellent in water resistance, the crayon comprising a colorant, a gelling agent, an organic solvent, a resin component, and a plasticizer, wherein the plasticizer is at least one selected from diisononyl adipate, acetyltributyl citrate, 1,2-cyclohexanedicarboxylic acid diisononyl, and alkylsulfonic acid phenyl ester and is contained in an amount of 1 to 20% by weight based on the crayon. | 2010-10-28 |
20100273915 | ASPHALT MODIFIER COMPOSITIONS WITH AN IMPROVED MELTING RATE AND MODIFIED ASPHALT PREPARED USING THE SAME - The present invention relates to a pellet type SBS-asphalt master batch modifier composition comprising styrene-butadiene-styrene (SBS) block copolymer and asphalt, and modified asphalt prepared by melting and mixing the pellet type SBS-asphalt master batch modifier composition with asphalt. The modified asphalt prepared thereof has advantages that deterioration of physical properties and thermal oxidation can be prevented while productivity can be improved due to reduced melting time of modifier. | 2010-10-28 |
20100273916 | ADMIXTURE FOR HYDRAULIC BINDER - A method includes adding at least one copolymer or a salt thereof acting as a plasticizer, blocking agent, or both a plasticizer and a blocking agent, to a calcium sulphate-based hydraulic binder. The copolymer includes an acrylic acid or a poly(oxy)alkylene copolymer. | 2010-10-28 |
20100273917 | BONDING WOOD COMPOSITES WITH A CALCIUM-MODIFIED PHENOL-FORMALDEHYDE RESIN - The present invention relates to an aqueous phenol-formaldehyde resole resin prepared by reacting phenol and formaldehyde in the presence of a source of calcium ions, to a curable powdered (particulate) resole resin made by spray drying the aqueous phenol-formaldehyde resole resin, to a method of preparing a wood composite using the curable, powdered resin, and the related wood composite bonded with the curable, powdered resin. | 2010-10-28 |
20100273918 | Mixtures of Bitumen and Polymer Compositions - A mixture comprising a bitumen (A), and a polymer composition (B) comprising the following components, all percent amounts being by weight: I) from 1 to 30% of a butene-1 polymer having a Melt Flow Rate (MFR), measured according to ASTM D 1238, at 190° C./2.16 kg, from 0.1 to 1000 g/10 min.; and II) from 70 to 99% of a heterophasic polyolefm composition comprising the following polymer fractions: a) 4-45% of a propylene homopolymer or copolymer; b) 0-20% of a of a copolymer fraction containing ethylene, insoluble in xylene at room temperature; c) 40-95% of a copolymer of ethylene with propylene and/or a CH | 2010-10-28 |
20100273919 | TWISTED PI-ELECTRON SYSTEM CHROMOPHORE COMPOUNDS WITH VERY LARGE MOLECULAR HYPERPOLARIZABILITIES AND RELATED COMPOSITIONS AND DEVICES - Unconventional twisted π-electron system electro-optic (EO) chromophores/compounds, compositions and related device structures. Crystallographic analysis of several non-limiting chromophores reveals, for instance, large ring-ring dihedral twist angles and a highly charge-separated zwitterionic structure in the ground state, in both solution phase and solid-state. | 2010-10-28 |
20100273920 | NOVEL HYDRODISPERSIBLE POLYISOCYANATE COMPOSITIONS - The present invention relates to a composition comprising:
| 2010-10-28 |
20100273921 | USE OF PHOSPHINIC ACIDS AND/OR PHOSPHONIC ACIDS IN POLYMERISATION PROCESSES - The present invention relates to the use of phosphinic acids and/or phosphonic acids and salts thereof for wetting fluorine compounds, in particular fluoropolymers, to the use in coating solutions comprising fluorine compounds, and to polymerisation processes in which fluorine compounds are used and/or formed. | 2010-10-28 |
20100273922 | Reinforced Thermoplastic Resin Composition And Molded Article - The present invention relates to a reinforced thermoplastic resin composition having excellent moldability, processability, and mechanical strengths, as well as being capable of improving the drop impact resistance (surface impact strength determined by a falling ball test). The reinforced thermoplastic resin composition of the present invention includes 10 to 60% by mass of a graft copolymer (A) having a graft chain (A2) grafted to a rubber polymer (A1); 40 to 90% by mass of a matrix polymer (B) which includes one or more types of polymers selected from the group consisting of a vinyl-based copolymer (B-1), a polycarbonate resin (B-2), and a polyester resin (B-3); 0.1 to 50 parts by mass of an inorganic filler (D) and 0.5 to 20 parts by mass of a glycidyl ether unit-containing polymer (E) having a mass average molecular weight of 3,000 to 200,000. | 2010-10-28 |
20100273923 | METHOD OF MANUFACTURING COMB POLYMERS BY ADDING AN ANTIOXIDANT, POLYMERS OBTAINED, AND APPLICATIONS THEREOF - The invention resides in the implementation of an antioxidant during the functionalization reaction of a (meth)acrylic polymer in a dry state by polyoxyalkylated lateral groups, so as to improve the grafting rate of the final polymer. The obtained polymers constitute another object of the invention, as do the aqueous formulations that they contain. | 2010-10-28 |
20100273924 | CURABLE COMPOSITIONS HAVING LESS VOLATILIZATION - The invention particularly relates to curable compositions comprising at least one polyisocyanate, at least one amine that is blocked by means of aldehyde or ketone, and at least one carboxylic acid hydrazide or sulfonic acid hydrazide which has a minimum melting point of 100° C., especially at least 150° C. Surprisingly, after being cured using moisture at room temperature and when being heated to increased temperatures, significantly fewer volatile components of such compositions volatilize than in the corresponding compositions that do not contain said hydrazide. | 2010-10-28 |
20100273925 | FLAMEPROOF EXPANDABLE STYRENE POLYMERS, AND METHOD FOR THE PRODUCTION THEREOF - Expandable styrene polymers (EPS) comprising, in each case based on the styrene polymer,
| 2010-10-28 |
20100273926 | FLAME RETARDANT POLYMER COMPOSITION COMPRISING POLYOLEFIN WITH HIGH MOLECULAR WEIGHT DISTRIBUTION - The present invention relates to a flame retardant polymer composition, comprising (A) a polyolefin comprising a Opolyolefin with a molecular weight distribution M | 2010-10-28 |
20100273927 | SILICONE RESIN COMPOSITION FOR OPTICAL SEMICONDUCTOR DEVICES AND AN OPTICAL SEMICONDUCTOR DEVICE - Silicone resin composition for optical semiconductor devices, providing cured product wherein warpage in the devices is reduced and whiteness, heat-resistance, and light resistance are improved. The composition comprises: (A) an organopolysiloxane of the formula | 2010-10-28 |
20100273928 | METHOD FOR PRODUCING FLAKY-GLASS GRANULE, FLAKY-GLASS GRANULE, AND RESIN COMPOSITION CONTAINING THE SAME - The method for producing flaky-glass granules of the present invention is a method for producing flaky-glass granules by allowing a plurality of glass flakes to be bonded to each other so as to be granulated. The method includes the steps of: (I) adding at least one liquid selected from water and a volatile organic solvent to the plurality of glass flakes and stirring a resultant mixture, and (II) drying the plurality of glass flakes stirred with the liquid added thereto. Unlike conventional flaky-glass granules, the flaky-glass granules produced by this method contain neither a binder nor a surface treatment agent for bonding the glass flakes to each other. Thus, when mixed into a thermoplastic resin to be molded at a high temperature, the flaky-glass granules cause neither foam inclusion nor discoloration in a molded article of the resin. | 2010-10-28 |
20100273929 | COLORING COMPOSITION - Disclosed is a coloring composition containing (A) a pigment dispersion composed of a pigment having an average particle diameter of 0.1-0.5 μm, a polymer dispersant containing a hydrophobic group and an ionic group as indispensable components and an aqueous medium, and (B) a crosslinking agent. The coloring composition is characterized in that a crosslinking reaction is caused between the polymer dispersant and the crosslinking agent at the time of coloring, thereby fixing the pigment onto fibers. | 2010-10-28 |
20100273930 | COATING AGENT AND METHOD FOR PRODUCTION THEREOF - Disclosed is a coating agent characterized by comprising: a core-shell-type resin particles (A) each having a shell layer and a core layer; a compound (B) having at least one selected from the group consisting of a hydrolysable silyl group and a silanol group and also having an epoxy group; and an aqueous medium, wherein the shell layer comprises (a1) a urethane resin with 2000 to 5500 mmol/kg of an aliphatic cyclic structure and at least one selected from the group consisting of a carboxyl group and a carboxylate group and the core layer comprises (a2) a vinyl polymer having a basic nitrogen-atom-containing group. Further disclosed are a coating agent for a plastic base material and a coating agent for a metallic base material. | 2010-10-28 |
20100273931 | DECARBOXYLATING BLOCK COPOLYMERS - Linear block copolymers that have at least one hydrophilic block and at least one hydrophobic block, wherein the hydrophilic block of the copolymer has at least one carboxylic acid functionality (or salt thereof) that can readily decarboxylate. These copolymers are useful as binders and/or dispersants in inkjet inks. | 2010-10-28 |
20100273932 | POLYISOCYANATE CONTAINING URETHANE GROUPS - The present invention relates to new, urethane-group-containing polyisocyanates based on isophorone diisocyanate and to their use. | 2010-10-28 |
20100273933 | POWDER COATING COMPOSITION - The invention provides a powder coating composition prepared from a combination, the combination comprising:
| 2010-10-28 |
20100273934 | CROSSLINKABLE VINYL ESTER COPOLYMERS AND THEIR USE AS LOW-PROFILE ADDITIVES - The invention relates to cross-linkable vinylester-copolymers obtained by means of radically initiated polymerisation of a) one or more vinyl esters and b) one or more ethylenically unsaturated, epoxy functional monomers, and by a subsequent reaction that is analogous to polymerisation of the thus obtained base polymers with one or more ethylenically unsaturated acids g), such that at least one ethylenically unsaturated, polymerizable group is introduced into each base polymer. Said invention is characterised in that the cross-linkable vinylester-copolymers have molecular weights of Mn of ≧6.500 g/mol. | 2010-10-28 |
20100273935 | ACRYLIC RUBBER COMPOSITION - [Problem] To provide an acrylic rubber composition that has an improved compression set, has substantially improved product performance, can prevent oil leakage in the above-described cycle tests, and has less curing deterioration of the rubber in the above-described curing deterioration tests. | 2010-10-28 |
20100273936 | Finishing Process for Amorphous Polymers - Extruded, copolymer pellet compositions and methods for making the same. A copolymer pellet composition can have an ethylene content of about 40 wt % to about 50 wt % and a propylene content of about 50 wt % to about 60 wt %, based on total weight of the copolymer, wherein the copolymer has a MFR (230° C./2.16 kg) of from about 3.0 g/10 min and about 25 g/10 min; a MWD (Mw/Mn) of about 2.3 or less; and no measurable melting peak, as measured by DSC. | 2010-10-28 |
20100273937 | ORGANOSILICON COMPOUND AND THERMOSETTING RESIN COMPOSITION CONTAINING THE SAME - An organosilicon compound which is obtained by subjecting a compound (A), a compound (B) and a compound (C) to hydrosilylation reaction: (A) silicone and/or silsesquioxane that has two or more Si—H groups per one molecule and has a molecular weight of 100 to 500,000; (B) silicone and/or silsesquioxane that has two or more alkenyl groups per one molecule and has a molecular weight of 100 to 500,000; and (C) a compound that has one or more epoxy or oxetanyl group and an alkenyl group having 2 to 18 carbon atoms per one molecule. | 2010-10-28 |
20100273938 | POLYISOCYANATES CONTAINING ALLOPHANATE GROUPS - The present invention relates to new, allophanate-group-containing polyisocyanates based on isophorone diisocyanate and to their use. | 2010-10-28 |
20100273939 | POLYURETHANE DISPERSIONS AND COATINGS PRODUCED THEREFROM - The present invention discloses polyurethane dispersions based on aliphatic isocyanates which form hard coatings wherein the coatings also have good solvent resistant properties. The enhanced properties of the coatings are achieved by including from 1 to 8 weight percent of a high functional polyol in the polyol formulation for producing the dispersions. | 2010-10-28 |
20100273940 | EPOXY RESIN CURING AGENT, PROCESS FOR PREPARING THE SAME, AND EPOXY RESIN COMPOSITION - It is an object of the present invention to provide an epoxy resin curing agent which has a favorable pot life and good storage stability as a curing agent for epoxy resins and from which an epoxy resin cured product having good water resistance and hardness is obtained through curing. The present invention is an epoxy resin curing agent containing a secondary or tertiary branched thiol compound having a substituent on a carbon atom at the α-position to a thiol group, and is also an epoxy resin composition comprising a polyvalent epoxy compound and the epoxy resin curing agent. | 2010-10-28 |
20100273941 | Thermally polymerizable resin composition - Disclosed is a water-soluble, thermally polymerizable oxetane composition essentially comprising a water-soluble oxetane compound and a heteropolyacid. The water-soluble thermally polymerizable oxetane resin composition essentially comprises (A) a water-soluble oxetane compound and (B) at least one heteropolyacid compound selected from heteropolyacids and heteropolyacid salts. The water-soluble oxetane compound may contain one or more oxetane functional groups in the molecule and one or more alcoholic OH groups in the molecule. The heteropolyacids include phosphotungstic acid, phosphomolybdic acid, silicotungstic acid, and silicomolybdic acid and mixtures thereof. The heteropolyacid salts include phosphotungstic acid salts, phosphomolybdic acid salts, silicotungstic acid salts, and silicomolybdic acid salts and mixtures thereof. | 2010-10-28 |